BMO Capital Markets Increases BioNTech (NASDAQ:BNTX) Price Target to $143.00
BioNTech (NASDAQ:BNTX – Get Free Report) had its price target boosted by investment analysts at BMO Capital Markets from $130.00 to $143.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. BMO Capital Markets’ target price indicates a potential upside of 42.56% from the company’s current price. […]
BioNTech (NASDAQ:BNTX – Get Free Report) had its price target boosted by investment analysts at BMO Capital Markets from $130.00 to $143.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. BMO Capital Markets’ target price indicates a potential upside of 42.56% from the company’s current price. […]
